These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 30818046

  • 1. Cytochrome P450 CYP2B6*6 distribution among Congolese individuals with HIV, Tuberculosis and Malaria infection.
    Peko SM, Gueye NSG, Vouvoungui C, Koukouikila-Koussounda F, Kobawila SC, Nderu D, Velavan TP, Ntoumi F.
    Int J Infect Dis; 2019 May; 82():111-116. PubMed ID: 30818046
    [Abstract] [Full Text] [Related]

  • 2. Allele and Genotype Frequencies of Cytochrome P450 2B6 516G>T Single Nucleotide Polymorphism in HIV-Negative and HIV-Infected Adult Nigerian Populations.
    Saʼad Toyin A, Julius Olugbenga S, Rahman Ayodele B, Olusola Joseph O, Taibat Moji BO.
    Am J Ther; 2016 May; 23(6):e1715-e1719. PubMed ID: 26938766
    [Abstract] [Full Text] [Related]

  • 3. High efavirenz serum concentrations in TB/HIV-coinfected Ugandan adults with a CYP2B6 516 TT genotype on anti-TB treatment.
    von Braun A, Castelnuovo B, Ledergerber B, Cusato J, Buzibye A, Kambugu A, Fehr J, Calcagno A, Lamorde M, Sekaggya-Wiltshire C.
    J Antimicrob Chemother; 2019 Jan 01; 74(1):135-138. PubMed ID: 30239753
    [Abstract] [Full Text] [Related]

  • 4. Effects of CYP2B6 and CYP1A2 Genetic Variation on Nevirapine Plasma Concentration and Pharmacodynamics as Measured by CD4 Cell Count in Zimbabwean HIV-Infected Patients.
    Mhandire D, Lacerda M, Castel S, Mhandire K, Zhou D, Swart M, Shamu T, Smith P, Musingwini T, Wiesner L, Stray-Pedersen B, Dandara C.
    OMICS; 2015 Sep 01; 19(9):553-62. PubMed ID: 26348712
    [Abstract] [Full Text] [Related]

  • 5. Efavirenz dosing: influence of drug metabolizing enzyme polymorphisms and concurrent tuberculosis treatment.
    Gengiah TN, Botha JH, Yende-Zuma N, Naidoo K, Abdool Karim SS.
    Antivir Ther; 2015 Sep 01; 20(3):297-306. PubMed ID: 25318122
    [Abstract] [Full Text] [Related]

  • 6. Dosage Optimization of Efavirenz Based on a Population Pharmacokinetic-Pharmacogenetic Model of HIV-infected Patients in Thailand.
    Chaivichacharn P, Avihingsanon A, Manosuthi W, Ubolyam S, Tongkobpetch S, Shotelersuk V, Punyawudho B.
    Clin Ther; 2020 Jul 01; 42(7):1234-1245. PubMed ID: 32451120
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of Cytochrome P450 2B6 Single Nucleotide Polymorphism in an HIV-Positive Cohort in Jos, Nigeria: Implication for HIV Therapy.
    Isaac AO, Wetkos DD, Oche AO, Godwin I, Phyllis K, John AC.
    Niger J Clin Pract; 2020 Dec 01; 23(12):1736-1743. PubMed ID: 33355828
    [Abstract] [Full Text] [Related]

  • 8. Distribution of the cytochrome P450 CYP2C8*2 allele in Brazzaville, Republic of Congo.
    Peko SM, Ntoumi F, Vouvoungui C, Nderu D, Kobawila SC, Velavan TP, Koukouikila-Koussounda F.
    Int J Infect Dis; 2019 Aug 01; 85():49-53. PubMed ID: 31078747
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Genetic variability of CYP2B6 polymorphisms in southeast Iranian population: implications for malaria and HIV/AIDS treatment.
    Zakeri S, Amiri N, Pirahmadi S, Dinparast Djadid N.
    Arch Iran Med; 2014 Oct 01; 17(10):685-91. PubMed ID: 25305768
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Impact of the Cytochrome P450 2B6 (CYP2B6) Gene Polymorphism c.516G>T (rs3745274) on Propofol Dose Variability.
    Mourão AL, de Abreu FG, Fiegenbaum M.
    Eur J Drug Metab Pharmacokinet; 2016 Oct 01; 41(5):511-5. PubMed ID: 26141406
    [Abstract] [Full Text] [Related]

  • 17. Human cytochrome P450 2B6 genetic variability in Botswana: a case of haplotype diversity and convergent phenotypes.
    Tawe L, Motshoge T, Ramatlho P, Mutukwa N, Muthoga CW, Dongho GBD, Martinelli A, Peloewetse E, Russo G, Quaye IK, Paganotti GM.
    Sci Rep; 2018 Mar 20; 8(1):4912. PubMed ID: 29559695
    [Abstract] [Full Text] [Related]

  • 18. Effects of rifampicin, CYP2B6 and ABCB1 polymorphisms on efavirenz plasma concentration in Chinese patients living with HIV and tuberculosis.
    Zhang L, Meng X, Dong P, Qi T, Liu L, Wang B.
    Int J STD AIDS; 2023 Jan 20; 34(1):37-47. PubMed ID: 36356965
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.